Full CoveragePurdue Pharma bankruptcy plan that shields Sackler family faces Supreme Court arguments
By Melissa Quinn
Top news
Court conflicted over Purdue Pharma bankruptcy plan that shields Sacklers from liability
By Amy Howe
The Opioid Victims Who Won't Sign Off on Purdue's $6 Billion Settlement
By Alexander Gladstone
Opinion: Is one $6-billion settlement enough of a reckoning for the family that brought us the opiod crisis?
By Robin Abcarian
Spotify layoffs and the Supreme Court reviews Sackler family immunity: Morning Rundown
All coverage
The Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake
By Mark Sherman
From the Boy Scouts to the Catholic Church, an upcoming Supreme Court ruling may mean some victims won’t see their day in court
By Samantha Delouya
US Supreme Court torn over Purdue Pharma bankruptcy settlement
By Andrew Chung & John Kruzel
Purdue bankruptcy plan, Sackler opioid immunity argued at Supreme Court
By David Ovalle & Robert Barnes
Supreme Court considers $6bn deal that shields Sacklers
By Brandon Drenon
US Supreme Court scrutinizes controversial opioid crisis settlement that would give Sackler family immunity
By Devan Cole & Samantha Delouya
Supreme Court wrestles with legal shield for Sackler family in Purdue Pharma bankruptcy plan
By Melissa Quinn
At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements?
By Abbie L. Vansickle
Opioid Victims Have a Settlement. Will the Supreme Court Undo It?
By Dan Powell, Alyssa Moxley & Will Reid
What to Know About the Purdue Pharma Case Before the Supreme Court
By Jan Hoffman & Abbie L. Vansickle
Supreme Court Appears Split Over Opioid Settlement for Purdue Pharma
By Abbie L. Vansickle
As high court weighs Purdue bankruptcy, opioid settlement divides victims
By David Ovalle & Robert Barnes